Veronica Popescu
Overpelt, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Cytomegalovirus Drives the Development of Cytotoxic CD4+ T Cells in Patients With Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 23, 2026
Directions for advancing prognostic assessments in multiple sclerosis: Qualitative Insights from MS specialist Interviews.
Journal: Journal of the neurological sciences
Published: August 25, 2025
Cognitive functioning in multiple sclerosis with focus on brainstem volume.
Journal: Acta neurologica Belgica
Published: June 04, 2025
Combining magnetic resonance imaging and evoked potentials enhances machine learning prediction of multiple sclerosis disability worsening.
Journal: Frontiers in immunology
Published: May 09, 2025
Leveraging hand-crafted radiomics on multicenter FLAIR MRI for predicting disability worsening in people with multiple sclerosis.
Journal: Frontiers in neuroscience
Published: May 02, 2025
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple Sclerosis.
Journal: European journal of neurology
Published: April 11, 2025
To halt disease progression rehabilitation in MS should start early: Commentary.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: November 16, 2024
The role of microglia in multiple sclerosis: implications for treatment with Bruton's tyrosine kinase inhibitors.
Journal: Frontiers in immunology
Published: September 12, 2024
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists.
Journal: European journal of neurology
Published: September 12, 2024
Smouldering-Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions.
Journal: Annals of neurology
Published: March 04, 2024
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.
Journal: Frontiers in immunology
Published: December 28, 2023
Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 18, 2023
Last Updated: 09/26/2026